Meta-Analysis
Copyright ©The Author(s) 2022.
World J Cardiol. Apr 26, 2022; 14(4): 250-259
Published online Apr 26, 2022. doi: 10.4330/wjc.v14.i4.250
Figure 1
Figure 1 PRISMA flow chart of study selection.
Figure 2
Figure 2 Association between angiotensin converting enzyme inhibitors adverse vascular outcomes. A: Post cardiac surgery shock; B: Vasoplegia.
Figure 3
Figure 3 Association between angiotensin converting enzyme inhibitors and need for inotropic support.
Figure 4
Figure 4 Association between other variables and post cardiac surgery shock. A: Beta blockers; B: Left ventricular dysfunction (EF < 40%); C: Cardiopulmonary bypass time (in minute).